Whole genome sequence of the rifamycin B-producing strain Amycolatopsis mediterranei S699
- PMID: 21914879
- PMCID: PMC3187414
- DOI: 10.1128/JB.05819-11
Whole genome sequence of the rifamycin B-producing strain Amycolatopsis mediterranei S699
Abstract
Amycolatopsis mediterranei S699 is an actinomycete that produces an important antibiotic, rifamycin B. Semisynthetic derivatives of rifamycin B are used for the treatment of tuberculosis, leprosy, and AIDS-related mycobacterial infections. Here, we report the complete genome sequence (10.2 Mb) of A. mediterranei S699, with 9,575 predicted coding sequences.
References
-
- Admiraal S. J., Walsh C. T., Khosla C. 2001. The loading module of rifamycin synthetase is an adenylation-thiolation didomain with tolerance for substituted benzoates. Biochemistry 40:6116–6123 - PubMed
-
- August P. R., et al. 1998. Biosynthesis of the ansamycin antibiotic rifamycin: deductions from the molecular analysis of the rif biosynthetic gene cluster of Amycolatopsis mediterranei S699. Chem. Biol. 5:69–79 - PubMed
-
- Bartels D., et al. 2005. BACCardI—a tool for the validation of genomic assemblies, assisting genome finishing and intergenome comparison. Bioinformatics. 21:853–859 - PubMed
-
- Dickinson J. M., Mitchison D. A. 1987. In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria. Tubercle 68:177–182 - PubMed
-
- Doi-Katayama Y., et al. 2000. Thioesterases and the premature termination of polyketide chain elongation in rifamycin B biosynthesis by Amycolatopsis mediterranei S699. J. Antibiot. (Tokyo) 53:484–495 - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
